Fezolinetant represents a significant advancement in the non-hormonal options for managing VMS associated with menopause. This module provides a summary of clinical evidence to support clinicians in identifying patients who are most likely to benefit from fezolinetant, enabling more personalized treatment options for women with VMS.
Identifying the Right Patients for Fezolinetant Therapy
CAN-eng
$0
gratuit
Non accrédité
6 min
Santé des femmes
0 Crédits
Description du cours
Détails du cours
Date d'expiration : 2027-02-06
Métiers: Physician, Nursing, Allied Health, Medical Resident, Student, Specialist
Faculté
Accréditation
Objectif(s) d'apprentissage
After viewing this microlearning, participants will be better able to:
- Identifier patients that may benefit the most from fezolinetant therapy